Canopy Growth has announced positive results from a six-month, randomised clinical trial studying the effects of cannabidiol (CBD) on menstrual-related symptoms.
The company said nearly 75% of reproductive-aged menstruating individuals report experiencing unpleasant menstrual-related symptoms, ranging from cramping and bloating to back pain and mood shifts iincluding irritability and stress.
The study, conducted in collaboration with James Madison University in Virginia over six months, saw 40 participants who experienced moderate to severe menstrual-related symptoms receive 160mg or 320mg of CBD in divided doses, twice daily for five days each month. Treatment began on the first day they experienced symptoms.
Results showed significantly reduced menstrual-related symptoms over the six months relative to a one-month baseline, and the higher dose was also effective in significantly reducing irritability and stress over the same period.
Canopy Growth vice president, human and animal research Dr Marcel O. Bonn-Miller said: “Our findings showed that CBD improves a variety of physical and psychological symptoms associated with menstruation and can be consumed in a targeted way around an individual’s menstrual cycle.
“Studies have shown that individuals report using cannabis to help manage their menstrual-related symptoms – however, no study had been conducted that examined the efficacy of cannabinoids in this area.”
Future research may be conducted to uncover the effectiveness of CBD at managing symptoms during an individual’s reproductive phases of life and beyond.